Literature DB >> 7842431

Early diagnosis of optic glioma in children with neurofibromatosis type 1.

L N Rossi1, G Pastorino, G Scotti, M Gazocchi, M M Maninetti, C Zanolini, A Chiodi.   

Abstract

Twenty-five asymptomatic patients with neurofibromatosis type 1 (NF 1), aged 6-21 years, underwent the following examinations: intracranial magnetic resonance testing (MRI), visual acuity testing, ophthalmoscopy, and visual field and pattern reversal visual evoked potentials (VEPs). MRI showed enlargement of one or both optic nerves in six children, with bilateral involvement in three. VEPs were normal in all these patients; two of them had abnormalities on other visual examinations, although there were no subjective visual disturbances. These results show that VEPs cannot be considered as a screening test for optic pathway lesions in children with NF 1, as previously stated, and that other types of visual function examination may be more sensitive. These data may contribute to the establishment of more precise guidelines for the evaluation and treatment of children with NF 1.

Entities:  

Mesh:

Year:  1994        PMID: 7842431     DOI: 10.1007/bf00303606

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  15 in total

1.  [Course of the visual evoked potentials in intracranial tuberculous granuloma].

Authors:  J Barrasa; C Quintial; V Madrigal; Y J Alonso
Journal:  Neurophysiol Clin       Date:  1990-05       Impact factor: 3.734

2.  The pattern-evoked potential in compression of the anterior visual pathways.

Authors:  A M Halliday; E Halliday; A Kriss; W I McDonald; J Mushin
Journal:  Brain       Date:  1976-06       Impact factor: 13.501

3.  Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study.

Authors:  R K Imes; W F Hoyt
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

4.  Optic glioma of childhood. Natural history and rationale for conservative management.

Authors:  W F Hoyt; S A Baghdassarian
Journal:  Br J Ophthalmol       Date:  1969-12       Impact factor: 4.638

5.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

6.  Neurofibromatosis and optic glioma: clinical and morphological correlations.

Authors:  J Stern; G V DiGiacinto; E M Housepian
Journal:  Neurosurgery       Date:  1979-06       Impact factor: 4.654

7.  Brain tumors in children with neurofibromatosis: computed tomography and magnetic resonance imaging.

Authors:  J Gray; K F Swaiman
Journal:  Pediatr Neurol       Date:  1987 Nov-Dec       Impact factor: 3.372

8.  Optic gliomas in children with neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; M J Greenwald; N B Esterly
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

9.  The value of visual evoked potential as a screening test in neurofibromatosis.

Authors:  B Jabbari; C G Maitland; L M Morris; J Morales; C H Gunderson
Journal:  Arch Neurol       Date:  1985-11

10.  Optic gliomas in children with neurofibromatosis type 1.

Authors:  A M Lund; F Skovby
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

View more
  8 in total

1.  Visual pathway glioma: an erratic tumour with therapeutic dilemmas.

Authors:  A Shuper; G Horev; L Kornreich; S Michowiz; R Weitz; R Zaizov; I J Cohen
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 2.  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.

Authors:  Klaus-Martin Kreusel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 3.  Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.

Authors:  C Van Mierlo; W Spileers; E Legius; I Casteels; C Cassiman
Journal:  Doc Ophthalmol       Date:  2013-07-25       Impact factor: 2.379

Review 4.  Special issues in the management of gliomas in children with neurofibromatosis 1.

Authors:  I F Pollack; J J Mulvihill
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

5.  Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.

Authors:  Patrícia de Freitas Dotto; Adriana Berezovsky; Andrea Maria Cappellano; Nasjla Saba da Silva; Paula Yuri Sacai; Frederico Adolfo B Silva; Arthur Gustavo Fernandes; Daniel Martins Rocha; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2018-05-15       Impact factor: 2.379

6.  Electrophysiological monitoring in a patient with an optic nerve glioma.

Authors:  Phillip Moradi; Anthony G Robson; Geoffrey E Rose; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2008-02-27       Impact factor: 2.379

7.  Visual evoked potentials in children with neurofibromatosis type 1.

Authors:  Alessandro Iannaccone; Richard A McCluney; Vickie R Brewer; Peter H Spiegel; June S Taylor; Natalie C Kerr; Enikö K Pivnick
Journal:  Doc Ophthalmol       Date:  2002-07       Impact factor: 2.379

8.  Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.

Authors:  Xiaonan Xi; Yahui Chu; Ning Liu; Qianqian Wang; Zheng Yin; Yaxin Lu; Yue Chen
Journal:  J Transl Med       Date:  2019-04-17       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.